RxDoctor Payments Data

Mohamed Shanshal, MD

Medical Oncology · Rochester, MNNPI 1538440649

Payments from drug & device makers

No general payments reported

No drug or device maker reported general payments to this provider for 2019–2025. That is a common and unremarkable result.

How this compares

$0 in reported general payments places this provider in the 0th percentile of 133 medical oncology providers in Minnesota.

See all medical oncology providers in Minnesota

Medicare billing

Part B allowed, 2024
$1,715,860
Medicare patients
396
Services billed
59,134

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
TagrissoOsimertinib Mesylate12$199,839
EliquisApixaban18$13,059
Prochlorperazine Maleate47$424
Olanzapine42$407
Ondansetron Hcl41$321
Dexamethasone74$309
Levothyroxine Sodium12$126
Prednisone33$112

Paid to pharmacies, not to this prescriber.

Other medical oncology in Rochester

See the full list for Minnesota

Where these figures come from

Is this you, or does something look wrong? →